These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8845569)

  • 41. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy.
    Powell JD; Ragheb JA; Kitagawa-Sakakida S; Schwartz RH
    Immunol Rev; 1998 Oct; 165():287-300. PubMed ID: 9850868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival.
    Burger R; Bakker F; Guenther A; Baum W; Schmidt-Arras D; Hideshima T; Tai YT; Shringarpure R; Catley L; Senaldi G; Gramatzki M; Anderson KC
    Br J Haematol; 2003 Dec; 123(5):869-78. PubMed ID: 14632778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myeloma biology and therapy. Present status and future developments.
    Nishimoto N; Shima Y; Yoshizaki K; Kishimoto T
    Hematol Oncol Clin North Am; 1997 Feb; 11(1):159-72. PubMed ID: 9081210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
    Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
    Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
    Tu Y; Gardner A; Lichtenstein A
    Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
    Hathcock KS; Laszlo G; Pucillo C; Linsley P; Hodes RJ
    J Exp Med; 1994 Aug; 180(2):631-40. PubMed ID: 7519245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD28-B7 interactions in T-cell activation.
    Allison JP
    Curr Opin Immunol; 1994 Jun; 6(3):414-9. PubMed ID: 7522466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study of IL-6 signal transduction pathway in a human multiple myeloma cell line--Sko-007].
    Song L; Li Y; Shen B
    Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):569-71. PubMed ID: 11225245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects on growth and survival of IL-6 can be dissociated in the U-266-1970/U-266-1984 and HL407E/HL407L human multiple myeloma cell lines.
    Spets H; Jernberg-Wiklund H; Sambade C; Söderberg O; Nilsson K
    Br J Haematol; 1997 Jul; 98(1):126-33. PubMed ID: 9233575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term bone marrow cultured stromal cells regulate myeloma tumour growth in vitro: studies with primary tumour cells and LTBMC-dependent cell lines.
    Bloem AC; Lamme T; de Smet M; Kok H; Vooijs W; Wijdenes J; Boom SE; Lokhorst HM
    Br J Haematol; 1998 Jan; 100(1):166-75. PubMed ID: 9450806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of B7-dependent responses in CD28-deficient mice.
    Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
    Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential role of CD28-B7 interactions in the growth of myeloma plasma cells.
    Kornbluth J
    Curr Top Microbiol Immunol; 1995; 194():43-9. PubMed ID: 7534672
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of interleukin 16 in multiple myeloma.
    Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
    J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
    Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
    Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?
    Kovacs E
    Leuk Res; 2010 Jul; 34(7):912-6. PubMed ID: 19762082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of helper T-cell precursor frequencies against non-haemopoietic cells: comparison of co-stimulation provided by anti-CD28 antibody versus the cellular ligand B7-1.
    van Dijk AM; de Gast GC; Kessler FL; Stadhouders-Keet SA; van Lier RA; Verdonck LF; Otten HG
    Br J Haematol; 2000 Aug; 110(2):322-6. PubMed ID: 10971388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro.
    Viret C; Gervois N; Guilloux Y; Le Dréan E; Diez E; Jotereau F
    Int Immunol; 1995 Oct; 7(10):1535-43. PubMed ID: 8562498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.
    Bergui L; Schena M; Gaidano G; Riva M; Caligaris-Cappio F
    J Exp Med; 1989 Aug; 170(2):613-8. PubMed ID: 2787832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands.
    Murtaza A; Kuchroo VK; Freeman GJ
    Int Immunol; 1999 Mar; 11(3):407-16. PubMed ID: 10221652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage.
    Mozaffari F; Hansson L; Kiaii S; Ju X; Rossmann ED; Rabbani H; Mellstedt H; Osterborg A
    Br J Haematol; 2004 Feb; 124(3):315-24. PubMed ID: 14717778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.